Mylan to recall all batches of blood pressure medicine valsartan in U.S.
Mylan NV said on Tuesday it is expanding a nationwide voluntary recall of its blood pressure medicine valsartan to include all lots, two weeks after it recalled select batches. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Mylan to recall all batches of blood pressure medicine in U.S.
Mylan NV said on Tuesday it is issuing a nationwide voluntary recall of all lots of its blood pressure medicine valsartan, expanding a recall of select batches initiated two weeks ago. (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Statins are being overprescribed, study suggests
The risks of statins for primary prevention are greater than the benefits for many patients Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Direct oral anticoagulants as safe as warfarin after VTE Too few women take part in many CVD clinical trials Use of DPP-4 inhibitors associated with increased risk of IBD Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2018 Category: UK Health Source Type: news
Teva Recalls Two Blood Pressure Medications
FRIDAY, Nov. 30, 2018 -- All lots of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination blood pressure tablets have been recalled by Teva Pharmaceuticals due to higher-than-acceptable levels of a chemical that may cause... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2018 Category: Pharmaceuticals Source Type: news
Class 2 Medicines Recall: Teva UK Limited and Mylan - recall of some Valsartan containing products
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a precautionary recall of all affected batches of Valsartan containing medicines made by Mylan and Teva UK Limited. This is du (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 30, 2018 Category: Drugs & Pharmacology Source Type: news
PIONEER: A Role for ARNI in Stabilized Acute HF? PIONEER: A Role for ARNI in Stabilized Acute HF?
Sacubitril/valsartan (Entresto) was studied in patients with acute decompensated heart failure in the PIONEER HF Trial. Dr Pi ñ a gets the details from lead investigator Eric Velazquez.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
ARNI on Par With Other HFrEF Strategies for Saving Lives Long Term
(MedPage Today) -- Sacubitril/valsartan yields " comparable " number needed to treat at 5 years (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 29, 2018 Category: Primary Care Source Type: news
Two More Valsartan Drugs Make Growing Recall List
All of the recalled products have ingredients manufactured in either China or India. The sudden rush of recalls because of ingredients made overseas has put more scrutiny on these foreign labs and on the FDA’s ability to effectively monitor their products for safety. (Source: WebMD Health)
Source: WebMD Health - November 28, 2018 Category: Consumer Health News Source Type: news
Another Valsartan Drug Makes Growing Recall List
All of the recalled products have ingredients manufactured in either China or India. The sudden rush of recalls because of ingredients made overseas has put more scrutiny on these foreign labs and on the FDA’s ability to effectively monitor their products for safety. (Source: WebMD Health)
Source: WebMD Health - November 28, 2018 Category: Consumer Health News Source Type: news
